Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Track-and-Trace Deal’s Failure Leaves California In Control Of Agenda

Executive Summary

Industry groups will continue to search for legislative vehicles to move a national standard that would preempt state laws; near-term, though, manufacturers and distributors must prepare for California pedigree law.

You may also be interested in...



FDA Secure Supply Chain Pilot Draws Small Group, But Could Serve Globalization Goals

Agency planned for up to 100 participants in program allowing expedited entry of some imports, but only approved 13.

Track-and-Trace Law: Push Begins For 2015 Exchange Standards

FDA has a tight deadline to finalize guidance on transaction information.

FDA Ready To Launch Secure Supply Chain Pilot

Program could allow for expedited entry of imports, but will be limited to 100 applicants and run for two years.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS054548

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel